About Us
About Us
Jiangsu BioScene Pharmaceutical Co., Ltd. was established in March 2020 and is a national high-tech enterprise located in Tianning Economic Development Zone, Changzhou City.
The company is an innovative biotech firm that drives the development of the entire pharmaceutical industry chain through new drug research and development. Its research and development mainly focuses on the development of 505(b)(2) class improved new drugs. The company's business model is based on the drug marketing authorization holder system, mainly focusing on the research and development of self-owned new drug products, with external technical services as a supplement. The company has strong R&D capabilities and has received honors such as the "Double Innovation Program" of Jiangsu Province and the "Longcheng Talent Program" of Changzhou City.
After years of accumulation, the company has successfully established two exclusive technology platforms and possesses core competitiveness in the research and development of improved new drugs.
News Center
根据百奥信康的发展需要，为进一步增进公司LOGO的识别性和传播效果，不断提升公司的品牌形象和影响力，公司决定，对百奥信康LOGO作如下调整。现将相关事项通知如下：
01
2025-06
2025年5月25日，江苏百奥信康医药科技有限公司在天宁区北塘河东路6号12幢8层公司新址隆重举行了主题为“启新程、创新篇”的新址乔迁仪式。此次乔迁标志着公司在发展历程中又迈出了坚实且重要的一步，开启了全新的发展篇章。
26
2025-05
2024年12月，江苏百奥信康医药有限公司在参与本年度江苏省食品药品监督检验研究院组织的能力验证工作中再获佳绩，在JSIFDC-PT-003紫外吸收系数法测定药品含量和JSIFDC-PT-004高效液相色谱法测定药品含量两项能力分别作为常州市唯一一家药品研发机构取得了“满意”结果，获得了《能力验证证书》。
20
2024-12
江苏百奥信康医药科技有限公司（以下简称“百奥信康”）与各合作方联合开发的左卡尼汀口服溶液（规格：10ml：1g）于2024年12月01日获得国家药品监督管理局批准上市。百奥信康感谢各合作方在开发过程中给予的大力支持和协助，期待各方继续紧密配合、相互支持，在该品种上市后的生产和销售方面再创佳绩。
04
2024-12
近日，江苏百奥信康医药科技有限公司（以下简称“百奥信康”）收到国家药品监督管理局核准签发的甲氨蝶呤片（规格：2.5mg）《药品注册证书》，证书编号：2024S02568。
06
2024-11
WeChat Official
TEL. /
E-mail /
ADD. /
Floor 8, Building 12, No.6 Beitanghe East Road, Tianning District, Changzhou, Jiangsu, PR China